NEWS 84 FEED & ADDITIVE MAGAZINE June 2022 Animal health technology company Covetrus has introduced Ascend - an innovative cloud-based Practice Management software (PMS) designed to enable veterinary practices. Covetrus introduces cloud-based practice management software Ascend Covetrus, a global leader in animal-health technology and services, introduced Ascend—a powerful, cloud-based Practice Management software (PMS) built to enable veterinary practices across the United Kingdom, EMEA and Asia Pacific. Ascend improves efficiency, streamlines internal communication and collaboration, and creates a better experience for staff and clients. Ascend offers a highly visual, dynamic interface that brings multiple systems together into one user-friendly platform - enabling stronger and better internal collaboration, as well as the ability to leverage the power of preferred third-party integrations, from scheduling and diagnostics, to billing and insurance, retail sales, and beyond. The introduction of Ascend comes on the heels of the successful beta period of Covetrus Pulse™, an innovative cloud-based veterinary operating system (vOS) in the United States and Canada that unites the best of Covetrus’ technologies into an all-in-one cloud platform. Covetrus Ascend, like Pulse, is part of Covetrus’ ongoing mission to be the premier provider of ‘Connected Care’ solutions designed to empower veterinarians with care management technologies that help to streamline workflows, save time, and improve outcomes. “With Ascend, we are thrilled to provide a one-stop shop on an intuitive platform that offers unparalleled functionality, along with the freedom to work from anywhere, at any time, on any device,” said Georgia Wraight, Executive Vice President and President of Global Technology Solutions at Covetrus. Deep Branch, Landsvirkjun partner to accelerate alternative proteins production Deep Branch, a creator of sustainable, high-value food and feed ingredients, signed a memorandum of understanding (MoU) with Landsvirkjun, the National Power Company of Iceland, to determine the feasibility of constructing Deep Branch’s first commercial-scale plant in Iceland. The facility will help scale the production of Proton, a single cell protein developed by Deep Branch for the animal feed industry. The agreement will see Deep Branch and Landsvirkjun collaborating to conduct a life cycle assessment (LCA) and techno-economic analysis (TEA). It will also affirm the companies’ commitment to work together and further explore the potential of eco-industrial clusters in Iceland. The outcomes of the TEA and LCA are expected to be delivered by the end of 2022. Following the construction of its pilot plant in the Netherlands, Deep Branch is now evaluating potential locations for future commercial-scale facilities to be built within the next five years. The availability of hydrogen – the required energy source for the company’s continuous fermentation process – will be a crucial factor in the selection process, as well as the proximity of downstream markets such as feed producers and aquafarmers.
RkJQdWJsaXNoZXIy MTUxNjkxNQ==